Automated Reminders for Colorectal Cancer Screening
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores ways to help people maintain their colorectal cancer screening routines, especially in rural areas with limited resources. It compares two approaches: one provides educational materials only, while the other includes automated call or text reminders about screenings. Individuals who have visited a participating health clinic in the past year, speak English, and are not up-to-date with their colorectal cancer screenings may be suitable for this study. As an unphased trial, it offers a unique opportunity to contribute to improving cancer screening adherence in underserved communities.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It seems unlikely that you would need to stop, as the trial focuses on reminders for colorectal cancer screening.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on promoting colorectal cancer screening and does not mention medication changes.
What prior data suggests that these automated reminders are safe for promoting CRC screening?
Research shows that automated call or text reminders safely help people remember to complete colorectal cancer screenings. Although specific safety data for these reminders is lacking, they are widely used in healthcare. These reminders function like appointment notifications via text or call.
Studies have found that reminders, such as phone calls and letters, are common in healthcare and usually don't cause harm. Automated reminders serve as another tool to help people maintain their health routines. While live phone calls can sometimes be more effective, automated texts and calls remain helpful and safe.
No reports of negative side effects have emerged from using automated reminders for health screenings, suggesting that people generally handle them well. Prospective participants in studies using these reminders can feel confident in their safety, based on their current use in healthcare.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores new ways to boost colorectal cancer (CRC) screening rates. Unlike traditional approaches that rely on patients remembering to schedule and attend screenings on their own, this trial uses automated reminders via calls and texts to nudge patients toward getting screened. By incorporating health literacy-appropriate educational materials and shared decision-making into the process, this approach aims to make the screening process easier and more accessible. This could lead to increased screening rates and earlier detection of CRC, potentially improving outcomes for many patients.
What evidence suggests that this trial's treatments could be effective for colorectal cancer screening?
Research has shown that automated calls and texts can increase participation in colorectal cancer screening. In this trial, participants in the PRIME CRC arm will receive these automated reminders to encourage screening. These reminders keep the screening on patients' minds, leading to higher screening rates. For example, automated calls are especially effective for older patients. Text message reminders also boost participation, though they might not be as effective if used alone. Overall, these strategies encourage more people to complete their screening tests, which is important for early detection of colorectal cancer.26789
Who Is on the Research Team?
Connie L Arnold, PhD
Principal Investigator
LSU Health Sciences Center Shreveport
Are You a Good Fit for This Trial?
The PRIME-CRC Trial is for English-speaking individuals aged 45 to 75 who have visited participating rural health clinics in the past year. It's not for those up-to-date with CRC screening, very ill patients, or those with cognitive impairments, significant hearing or vision issues, a family history requiring different screening due to risk factors, or a history of cancer other than non-melanoma skin cancer.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive patient-centered reminders and health literacy education to promote CRC screening adherence via colonoscopy or annual FIT
Follow-up
Participants are monitored for completion of CRC screening and adherence to screening guidelines
What Are the Treatments Tested in This Trial?
Interventions
- automated call reminders or automated texts
- health literacy appropriate education and demonstration
- shared decision making
Find a Clinic Near You
Who Is Running the Clinical Trial?
Louisiana State University Health Sciences Center Shreveport
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Northwestern University
Collaborator